Pregnancy and dermatologic therapy
Authors:
- 1 April 2013
- journal article
- review article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 68 (4) , 663-671
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Isotretinoin and iPledge: A view of resultsJournal of the American Academy of Dermatology, 2011
- Corticosteroid use during pregnancy and risk of orofacial cleftsCanadian Medical Association Journal, 2011
- Isotretinoin, pregnancies, abortions and birth defects: a population‐based perspectiveBritish Journal of Clinical Pharmacology, 2007
- A risk management program aimed at preventing fetal exposure to isotretinoin: Retrospective cohort studyJournal of the American Academy of Dermatology, 2006
- Prevalence and Treatment of Psoriasis in the United KingdomArchives of Dermatology, 2005
- American Academy of Dermatology Consensus Conference on the safe and optimal use of isotretinoin: summary and recommendationsJournal of the American Academy of Dermatology, 2004
- Low or high doses of spironolactone for treatment of maternal Bartter's syndromeAmerican Journal of Obstetrics and Gynecology, 1996
- Cutaneous surgery and the pregnant patientJournal of the American Academy of Dermatology, 1990
- Maternal-fetal absorption of povidone-iodineThe Journal of Pediatrics, 1984
- Aminopterin and methotrexate: Folic acid deficiencyTeratology, 1978